| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5846ed1722d0bb1186befbfb2b991232 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10101 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7264
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-00 |
| filingDate |
2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e25f0f875775e489a7b01acd0915c55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b632cf4c6438e51aaa673f55e697bf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48175fece54266517d20f94fa2baf538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82270784a75d3f2e7105d3618700d794 |
| publicationDate |
2015-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9179839-B2 |
| titleOfInvention |
Method for determining at least one diagnosis or risk assessment parameter related to AMD |
| abstract |
A method for Determining at Least One Parameter for Diagnosis or Risk Assessment of a Disease, including AMD. The distribution of the macular pigment MP of an eye and at least one area A whose bordering line corresponds to a constant optical density MPD and/or concentration MPC of MP is determined by an analysis unit. The bordering line is subjected to a quantitative shape description. At least one parameter DP, suitable for diagnosing a disease and/or the risk of a disease is derived from the quantitative shape description of the bordering line of the areas A. The method is provided for diagnosis or risk assessment but may also be used in the context of treatment of macular pigment deficiency phenomena to select the required supplements. This method, based on the determination of the fractal dimension, is also suitable for diagnosing other diseases such as edemas, actinomycoses, atrophies or lesions. |
| priorityDate |
2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |